Day 9 part 1
๐งฌ Molecular Dynamics Simulations โ Theoretical Summary
Source:
๐ฏ Why Molecular Dynamics (MD) simulations exist
In experiments, proteins exist as ensembles of many conformations in solution. But when we look at a structure on a screen (e.g., PDB), we see only one static conformation.
MD simulations aim to:
โ Mimic how atoms move in real life โ Explore all possible conformations over time โ Understand thermodynamic averages โ Reveal motions that are experimentally hard to observe
You can think of MD as a โcomputational microscopeโ โ it lets us observe atomic motion with time resolution that experiments often cannot achieve.
๐ฒ Monte Carlo vs Molecular Dynamics
Two major simulation approaches exist:
๐ฒ Monte Carlo (MC)
- Samples conformations randomly
- Gives statistical distribution of states
- No time information
๐ Example idea: Like roulette statistics โ you only know how often something happens.
โฑ Molecular Dynamics (MD)
- Simulates real motion over time
- Conformations are connected through physical trajectories
๐ Therefore MD can reveal mechanisms, not just probabilities.
โฐ Potential Energy Surface (Energy Landscape)
A key theoretical concept.
Proteins move on an energy landscape.
๐ฝ Energy minima
- Low-energy conformations
- Most stable โ most likely in nature
โ Yes โ in thermodynamics, systems tend toward minimum free energy states (but not always global minimum due to kinetic barriers).
๐ Global minimum
- Absolute lowest energy state
- Often considered the native fold
๐ช Local minima
- Metastable states
- Protein can get โtrappedโ there
๐ช Saddle Point (Important!)
A saddle point is:
- Maximum in one direction
- Minimum in another direction
Meaning:
โก It represents a transition pathway between two conformations. โก It is related to activation barriers in conformational change.
So MD helps identify:
- Which conformational change route is easiest
- Which barrier must be crossed
This is fundamental for:
- Folding
- Channel gating
- Ligand binding pathways
โ๏ธ How MD simulation actually works
Basic algorithm:
- Start with structure
- Let atoms move for a tiny time step (~femtoseconds)
- Stop
- Calculate all forces
- Update velocities and positions
- Repeat
Thus:
๐ Motion becomes a time-resolved trajectory.
This is based on:
- Newtonโs laws
- Potential energy function
๐ Do atoms need to be bonded to interact?
โ No.
Atoms only need to be close enough.
This means MD includes:
- Protein-protein interactions
- Protein-solvent interactions
- Lipid interactions
- Ion interactions
So yes โ protein solvent effects are explicitly modeled.
This is extremely important because:
- Water stabilizes structure
- Solvation influences folding
- Channels allow transport
๐งช Why can ions not pass membranes freely?
Because lipid bilayers are:
- Hydrophobic
- Energetically unfavorable for charged species
Thus:
โ Ions must pass via channel proteins
Experimentally:
- You can detect current
- But cannot easily track atomic path
To locate ions structurally:
- You would need to freeze motion
- Then crystallize
Very difficult โ MD provides dynamic insight.
๐ Drug binding theory in MD
Docking vs MD difference:
Docking
- Often treats receptor as rigid
- Ligand flexible
- Cannot capture induced fit well
MD
- Protein and ligand both flexible
- Can observe binding pathways
๐งญ Two strategies for ligand binding simulations
Strategy 1 โ Start ligand inside
- Run MD โ observe how it leaves
- Reverse trajectory โ infer entry path
Strategy 2 โ Start ligand outside
- Apply pulling force
- Guide ligand into active site
These approaches help understand:
- Binding kinetics
- Entry channels
- Energy barriers
โณ Binding strength interpretation
If ligand:
- Leaves quickly โ weak binding
- Stays long โ strong binding
Residence time correlates with:
๐ Binding affinity
This is crucial in drug design.
๐ Allosteric regulation
MD can reveal:
- Which ligand binds first
- How binding changes shape elsewhere
- Cooperative mechanisms
This is difficult with static docking.
๐ Protein functional mechanisms
Example:
Active โ inactive transition.
If ligand removed:
- Protein may relax to inactive form
- MD shows structural pathway
Thus MD explains:
โ Signal transduction โ Channel gating โ Receptor activation
๐งฌ Protein folding theory
Huge challenge.
Reasons:
- Unknown unfolded starting structure
- Folding occurs over microsecondsโseconds
- Requires enormous computing power
Historically:
- Distributed computing (Folding@home)
- Now GPU computing accelerates simulations
๐ก Why static structures are misleading
A crystal/NMR structure is:
โ A snapshot of a dynamic system
Like photographing a running horse mid-air and concluding it can fly.
Also:
- Structure has no temperature
- No vibrational motion
- Effectively resembles 0 K condition
Thus simulations must:
๐ฅ Heat system โ equilibration phase
- Adjust velocities
- Stabilize pressure and temperature
๐ Production phase
- Collect meaningful data
๐งฎ Force fields โ core theoretical idea
Force field =
๐ Large lookup table of parameters:
- Bond lengths
- Angles
- Charges
- van der Waals terms
Speeds up simulation because:
- Bonded interactions pre-parameterized
- Only non-bonded interactions calculated dynamically
โ ๏ธ Limitation
Force fields are not universal.
Each has:
- Specific strengths
- Specific failures
Therefore:
โ Always check what force field cannot do before using it.
๐ข Time-scale problem in MD
Different motions:
- Bond vibrations โ very fast
- Side chain rotations โ medium
- Loop movements โ very slow
Thus:
To observe large conformational change:
๐ Need long simulation time.
๐ Drug โon-offโ behavior โ why dynamic binding can be better
Important theoretical pharmacology insight:
A drug that:
- Binds โ unbinds โ rebinds
may be better than one that binds permanently.
Why?
Because:
- Real biological channels open and close
- Dynamic drugs mimic physiology
- Permanent blockers may cause toxicity
MD helps evaluate such behavior.
โญ Key Takeaway
Molecular dynamics is fundamentally about:
Understanding how biomolecules move on an energy landscape over time.
It connects:
- Thermodynamics
- Kinetics
- Structure
- Function
- Drug action
into one theoretical framework.